Oral COVID-19 antiviral prescribing in Australian general practice – a retrospective observational study
Australian Journal of Primary Health · 2025
DOI: 10.1071/py24170 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Australian Journal of Primary Health, 2025. Verfasst von Judith Thomas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Australian Institute of Health Innovation, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19, COVID-19 Drug Treatment, Drug Prescriptions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Digital Health CRC.
Abstract (Originalsprache)
Background
This study aimed to gain a comprehensive understanding of oral COVID-19 antiviral prescribing in Australian general practice.
Methods
The study was a retrospective observational cohort study. Routinely collected, de-identified, Australian general practice consultation and prescription data was used with permission from participating primary health networks, from 938 general practices between March 2022 and September 2023. Study cohorts were patients aged ≥15 encompassing (i) an ‘antiviral cohort’ comprising patient records with ≥1 oral COVID-19 antiviral prescription/s and (ii) a ‘comparison cohort’ of remaining records. Primary outcome measures were the frequency and type of oral COVID-19 antivirals prescribed, and sociodemographic and health characteristics of patients prescribed antivirals. Secondary measures were the frequency of antiviral repeat prescribing and consultation modality.
Results
Within the study population of 3,813,051 patients, oral COVID-19 antivirals were prescribed to 3.39% (129,267) of patients including 14.79% (82,215/555,757) of patients aged ≥70 years. Molnupiravir prescribing exceeded nirmatrelvir–ritonavir across all study months. Proportionally, antiviral prescribing was higher in the female population (74,709/2,059,676: 3.63%), Victoria (81,184/2,222,837: 3.65%), residing in high socioeconomic advantage areas (87,530/2,224,501: 3.93%), and ages 80–84 years (16,419/100,911: 16.27%). Of patients prescribed COVID-19 antivirals, 7.27% (9402/129,267) had repeat prescribing. Cardiovascular and musculoskeletal conditions were the most prevalent chronic diagnoses, and telehealth (58,660/107,727: 54.45%) exceeded face-to-face consultations.
Conclusions
Oral COVID-19 antiviral prescribing volumes in general practice may serve as an indicator of periods of increased transmission of COVID-19, through increases in prescribing activity. Telehealth exceeding face-to-face for oral COVID-19 antiviral prescribing supports continued access to telehealth to reduce exposure to COVID-19 and provide time-critical access to treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Australian Institute of Health Innovation, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia.
- Outcome Health, Melbourne, Vic 3130, Australia.
- Eastern Melbourne Primary Health Network, Melbourne, Vic 3128, Australia.
- Langpark Medical Centre, Melbourne, Vic 3910, Australia.
Förderung
- Digital Health CRC
Zitieren
APA
Thomas, J., Kamalakkannan, A., Prgomet, M., Gardner, K., McGuire, P., Campbell, G., & Georgiou, A. (2025). Oral COVID-19 antiviral prescribing in Australian general practice – a retrospective observational study. Australian Journal of Primary Health. https://doi.org/10.1071/py24170
Vancouver
Thomas J, Kamalakkannan A, Prgomet M, Gardner K, McGuire P, Campbell G, et al. Oral COVID-19 antiviral prescribing in Australian general practice – a retrospective observational study. Australian Journal of Primary Health. 2025. doi:10.1071/py24170
BibTeX
@article{Thomas2025,
author = {Thomas, Judith and Kamalakkannan, Abbish and Prgomet, Mirela and Gardner, Karina and McGuire, Precious and Campbell, Geoffrey and Georgiou, Andrew},
title = {Oral COVID-19 antiviral prescribing in Australian general practice – a retrospective observational study},
journal = {Australian Journal of Primary Health},
year = {2025},
doi = {10.1071/py24170}
}
EUVIMED